Header

UZH-Logo

Maintenance Infos

Cre-driver lines used for genetic fate mapping of neural crest cells in the mouse: An overview


Debbache, Julien; Parfejevs, Vadims; Sommer, Lukas (2018). Cre-driver lines used for genetic fate mapping of neural crest cells in the mouse: An overview. Genesis, 56(6-7):e23105.

Abstract

The neural crest is one of the embryonic structures with the broadest developmental potential in vertebrates. Morphologically, neural crest cells emerge during neurulation in the dorsal folds of the neural tube before undergoing an epithelial-to-mesenchymal transition (EMT), delaminating from the neural tube, and migrating to multiple sites in the growing embryo. Neural crest cells generate cell types as diverse as peripheral neurons and glia, melanocytes, and so-called mesectodermal derivatives that include craniofacial bone and cartilage and smooth muscle cells in cardiovascular structures. In mice, the fate of neural crest cells has been determined mainly by means of transgenesis and genome editing technologies. The most frequently used method relies on the Cre-loxP system, in which expression of Cre-recombinase in neural crest cells or their derivatives genetically enables the expression of a Cre-reporter allele, thus permanently marking neural crest-derived cells. Here, we provide an overview of the Cre-driver lines used in the field and discuss to what extent these lines allow precise neural crest stage and lineage-specific fate mapping.

Abstract

The neural crest is one of the embryonic structures with the broadest developmental potential in vertebrates. Morphologically, neural crest cells emerge during neurulation in the dorsal folds of the neural tube before undergoing an epithelial-to-mesenchymal transition (EMT), delaminating from the neural tube, and migrating to multiple sites in the growing embryo. Neural crest cells generate cell types as diverse as peripheral neurons and glia, melanocytes, and so-called mesectodermal derivatives that include craniofacial bone and cartilage and smooth muscle cells in cardiovascular structures. In mice, the fate of neural crest cells has been determined mainly by means of transgenesis and genome editing technologies. The most frequently used method relies on the Cre-loxP system, in which expression of Cre-recombinase in neural crest cells or their derivatives genetically enables the expression of a Cre-reporter allele, thus permanently marking neural crest-derived cells. Here, we provide an overview of the Cre-driver lines used in the field and discuss to what extent these lines allow precise neural crest stage and lineage-specific fate mapping.

Statistics

Citations

Dimensions.ai Metrics
7 citations in Web of Science®
7 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

212 downloads since deposited on 22 May 2018
147 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Institute of Anatomy
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Uncontrolled Keywords:Genetics, Cell Biology, Endocrinology
Language:English
Date:19 April 2018
Deposited On:22 May 2018 13:22
Last Modified:24 Sep 2019 23:29
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1526-954X
OA Status:Green
Publisher DOI:https://doi.org/10.1002/dvg.23105
PubMed ID:29673028

Download

Green Open Access

Download PDF  'Cre-driver lines used for genetic fate mapping of neural crest cells in the mouse: An overview'.
Preview
Content: Accepted Version
Language: English
Filetype: PDF
Size: 510kB
View at publisher
Download PDF  'Cre-driver lines used for genetic fate mapping of neural crest cells in the mouse: An overview'.
Preview
Content: Published Version
Filetype: PDF
Size: 1MB
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)